A San Diego-based biotech company is turning heads Tuesday morning after the company announced that its partner, Melinta Therapeutics, has launched Rezzayo, a treatment for...

To read the full story on AllPennyStocks.com, click here.

Cidara Therapeutics (NASDAQ:CDTX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Cidara Therapeutics.
Cidara Therapeutics (NASDAQ:CDTX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Cidara Therapeutics.